Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Our AI scores Kenvue Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Kenvue Inc. is a large-cap company with a market capitalization of $37.11B. It ranks number 4 by market capitalization among the 16 Perfumes, Cosmetics & Other Toilet Preparations issuers in our coverage with a current forecast.
For KVUE, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 8.0%, measured on 316 forecast dates between 2023-06-02 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -2.0%, measured on 359 forecast dates between 2023-06-02 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, KVUE included.
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Perfumes, Cosmetics & Other Toilet Preparations peers listed below that report each metric.
| Metric | KVUE | Rank |
|---|---|---|
| Market Cap | $37.11B | 4/16 |
| P/E Ratio | 25.08x | 5/8 |
| P/B Ratio | 3.65x | 6/12 |
| Dividend Yield | 4.30% | 1/5 |
| EPS | $0.77 | – |
| Book Value/Share | $5.29 | – |
| Revenue/Share | $8.08 | – |
| FCF/Share | $1.22 | – |
| Metric | KVUE | Rank |
|---|---|---|
| ROE | 16.6% | 5/11 |
| ROA | 6.3% | 5/14 |
| ROIC | 13.2% | 6/13 |
| Gross Margin | 58.3% | 8/14 |
| Operating Margin | 17.4% | 4/15 |
| Net Margin | 10.9% | 3/14 |
| EBT Margin | 14.8% | 4/15 |
| Tax Rate | 26.7% | – |
| Metric | KVUE | Rank |
|---|---|---|
| Current Ratio | 0.96x | 10/15 |
| Quick Ratio | 0.66x | 10/15 |
| D/E Ratio | 1.62x | 6/13 |
| Financial Leverage | 2.62x | 6/13 |
| Interest Coverage | 6.8x | 5/12 |
| Working Capital | -$277M | 12/15 |
| Metric | KVUE | Rank |
|---|---|---|
| Operating Cash Flow | $2.73B | 3/15 |
| Free Cash Flow | $2.34B | 3/11 |
| Capital Spending | -$393M | 8/11 |
| OCF Growth YoY | 27.9% | 4/9 |
| FCF Growth YoY | 42.6% | 5/10 |
| FCF/Sales | 15.1% | 5/11 |
| CapEx/Sales | 2.5% | 5/11 |
| Metric | KVUE | Rank |
|---|---|---|
| Asset Turnover | 0.58x | 11/13 |
| Receivables Turnover | 6.2x | 10/12 |
| Inventory Turnover | 3.6x | 5/14 |
| Fixed Assets Turnover | 7.0x | 10/13 |
| Days Sales Outstanding | 59 days | 3/12 |
| Days Inventory | 102 days | 9/14 |
| Payables Period | 151 days | 2/13 |
| Cash Conversion Cycle | 10 days | 9/11 |
| Metric | KVUE | Rank |
|---|---|---|
| Total Revenue | $15.53B | 3/13 |
| Operating Income | $2.71B | 3/15 |
| Net Income | $1.69B | 2/14 |
| R&D Expense | $372M | 2/5 |
| SG&A Expense | $6.09B | 4/12 |
| Cost of Goods Sold | $6.48B | 3/14 |
| Metric | KVUE | Rank |
|---|---|---|
| Dividends Per Share | $0.83 | – |
| Payout Ratio | 107.8% | – |
| Shares Outstanding | 1922M | – |
| Net Income Growth | 17.9% | 2/8 |
| EPS Growth | 40.0% | 2/7 |
| Total Current Assets | $5.94B | 22.3% of assets |
| Cash & Short-term Investments | $1.04B | 3.9% of assets |
| Accounts Receivable | $2.50B | 9.4% of assets |
| Inventory | $1.81B | 6.8% of assets |
| Total Liabilities | $16.51B | 61.9% of assets |
| Short-term Debt | $3.53B | 13.2% of assets |
Companies classified under the same SEC industry code as Kenvue Inc. (Perfumes, Cosmetics & Other Toilet Preparations): 16 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| KVUE Kenvue Inc. | $37.11B | |
| CL Colgate Palmolive Co | $76.76B | |
| HLN Haleon Plc | $40.10B | |
| EL Estee Lauder Companies Inc | $39.82B | |
| ELF E.L.F. Beauty, Inc. | $6.85B | |
| IPAR Interparfums Inc | $4.34B | |
| COTY Coty Inc. | $3.57B | |
| EPC Edgewell Personal Care Co | $1.29B | |
| ODD Oddity Tech Ltd | $931M | |
| SLSN Solesence, Inc. | $61M | |
| AXIL Axil Brands, Inc. | $35M | |
| UG United Guardian Inc | $31M | |
| SHFH Scientist Home Future Health Ltd | $25M | |
| KARX Karbon-X Corp. | $16M | |
| CABR Caring Brands, Inc. | $8M | |
| YCBD Cbdmd, Inc. | $4M |
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Skillman, New Jersey-based Kenvue Inc. (KVUE) operates as a consumer health company worldwide. Valued at $37.1 billion by ...
Toward the end of the October 1 lightning round of Mad Money, a caller asked about Kimberly-Clark Corporation (NASDAQ:KMB) and its pending acquisition of Kenvue Inc. (NYSE:KVUE). They highlighted ...
Our AI scores Kenvue Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
For KVUE, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 8.0%, measured on 316 forecast dates between 2023-06-02 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -2.0%, measured on 359 forecast dates between 2023-06-02 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Kenvue Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
16 issuers in our coverage, KVUE included, share the SEC industry code Perfumes, Cosmetics & Other Toilet Preparations. The largest are: Colgate Palmolive Co (CL), Haleon Plc (HLN), Estee Lauder Companies Inc (EL), E.L.F. Beauty, Inc. (ELF), Interparfums Inc (IPAR), Coty Inc. (COTY).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.
